Evidence map›Paper›PMID 37346176›Full record

ArticleFrontiers in cell and developmental biology2023

Aberrant protein targeting activates quality control on the ribosome.

Zemfira N Karamysheva, Andrey L Karamyshev

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Human SRP Subunits Coordinate Protein Targeting and mRNA Quality Control.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Pathogenic signal peptide variants in the human genome.NAR genomics and bioinformatics · 2023
    Article
  6. Amyloid Precursor Protein and Alzheimer's Disease.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zemfira N KaramyshevaDepartment of Biological Sciences, Texas Tech University, Lubbock, TX, United States.
Andrey L KaramyshevDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
Texas Tech University · US

Funding

Regulation of Aberrant Protein ProductionR01GM135167 · NIGMS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI KARAMYSHEV, ANDREY L · 2019 to 2022
$1.3M
NIGMS NIH HHS R01 GM135167
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diseaseprotein quality controlprotein sortingprotein targeting and transportribosomeRNA degradationsignal peptidesignal recognition particle (SRP)

Identifiers

PMID37346176
PMCPMC10279951
OpenAlexW4379538233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.